Association between bone measures and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
Version 2 2024-06-06, 00:10Version 2 2024-06-06, 00:10
Version 1 2021-10-01, 07:56Version 1 2021-10-01, 07:56
journal contribution
posted on 2024-06-06, 00:10 authored by KL Holloway-Kew, Amelia BetsonAmelia Betson, KB Anderson, J Gaston, MA Kotowicz, WH Liao, M Henneberg, Julie PascoJulie PascoAssociation between bone measures and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
History
Journal
Archives of OsteoporosisVolume
16Article number
ARTN 137Pagination
1 - 10Location
EnglandISSN
1862-3522eISSN
1862-3514Language
EnglishPublication classification
C1 Refereed article in a scholarly journalIssue
1Publisher
SPRINGER LONDON LTDUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineEndocrinology & MetabolismOrthopedicsAngiotensin-converting enzyme inhibitorsAngiotensin II receptor blockersBone mineral densityTrabecular bone scoreMINERAL DENSITYANTIHYPERTENSIVE MEDICATIONSRISKFRACTURESSYSTEMDRUGSOSTEOPOROSISHYPERTENSIONALDOSTERONECOHORT4202 Epidemiology
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC